 - Participant has been diagnosed with, or has a malignancy other than adequately treated basal cell or squamous cell carcinoma of the skin or carcinoma in situ of the cervix within the last 12 months prior to enrollment; participants treated with immunosuppressive chemotherapeutic agents during this period are excluded 